PTC Therapeutics, Inc. (PTCT): Director sold ~$270K

~$270K

Approx. value · 5,000 sh @ $54.00

8,867

Holds after · shares reported

Traded

Mar 13, 2025

Filed

Mar 17, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Feb 19, 2025Insider · 7 peopleInsiders: 8 sales (~$540K)
2. Feb 20, 2025Insider · 7 peopleInsiders: 8 sales (~$586K)
3. Mar 4, 2025InsiderDirector sold ~$63K of PTCT shares in the open market
4. Mar 10, 2025Insider · 1 personInsiders: 4 sales (~$3.6M)
5. Mar 11, 2025InsiderOfficer sold ~$300K of PTCT shares in the open market
6. Mar 12, 2025Insider · 1 personInsiders: 2 sales (~$827K)
7. Mar 13, 2025 · this disclosureInsiderDirector sold ~$270K of PTCT shares in the open market

What came next

1. Mar 14, 2025InsiderOfficer sold ~$246K of PTCT shares in the open market
2. Mar 17, 2025Insider · 1 personInsiders: 4 sales (~$384K)
3. Apr 2, 2025InsiderOfficer sold ~$42K of PTCT shares in the open market
4. Apr 22, 2025InsiderCEO sold ~$137K of PTCT shares in the open market
5. May 15, 2025InsiderOfficer sold ~$89K of PTCT shares in the open market
6. May 16, 2025InsiderOfficer sold ~$41K of PTCT shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for PTC Therapeutics, Inc.

For PTC Therapeutics, Inc., OQRO holds 12 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PTCT page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at PTC Therapeutics, Inc.

• SEC Form 4Oct 16, 2026
• SEC Form 4Oct 16, 2026
• SEC Form 4Oct 13, 2026
• SEC Form 144Oct 9, 2026
• SEC Form 4Oct 9, 2026
• SEC Form 4Oct 9, 2026

Everything OQRO holds on this company is on its PTCT page.